- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Weight-loss Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Weight-loss Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Weight-loss Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Weight-loss Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Weight-loss Drugs market size and forecasts, by Type and by Sales Channels, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Weight-loss Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Weight-loss Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Weight-loss Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd and Swiss Research Labs Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Weight-loss Drugs market is split by Type and by Sales Channels. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channels in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liquid
Powder
Softgels
Pills
Others
Market segment by Sales Channels
Online Sales
Hospitals and Clinics
Pharmacy
Others
Major players covered
Novo Nordisk
Currax
Ultimate life ltd
Wolfson Berg Ltd
Swiss Research Labs Ltd.
Roar Ambition
Health and Nutrition Ltd.
Abbott
Kellogg Company
Glanbia PLC
Ajinomoto Co. Inc.
Kraft Heinz Company
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
PepsiCo
Nestle
Amway Corp.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Weight-loss Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Weight-loss Drugs, with price, sales, revenue and global market share of Weight-loss Drugs from 2018 to 2023.
Chapter 3, the Weight-loss Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Weight-loss Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sales channels, with sales market share and growth rate by type, sales channels, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Weight-loss Drugs market forecast, by regions, type and sales channels, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Weight-loss Drugs.
Chapter 14 and 15, to describe Weight-loss Drugs sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Weight-loss Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Weight-loss Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Liquid
1.3.3 Powder
1.3.4 Softgels
1.3.5 Pills
1.3.6 Others
1.4 Market Analysis by Sales Channels
1.4.1 Overview: Global Weight-loss Drugs Consumption Value by Sales Channels: 2018 Versus 2022 Versus 2029
1.4.2 Online Sales
1.4.3 Hospitals and Clinics
1.4.4 Pharmacy
1.4.5 Others
1.5 Global Weight-loss Drugs Market Size & Forecast
1.5.1 Global Weight-loss Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Weight-loss Drugs Sales Quantity (2018-2029)
1.5.3 Global Weight-loss Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Weight-loss Drugs Product and Services
2.1.4 Novo Nordisk Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Currax
2.2.1 Currax Details
2.2.2 Currax Major Business
2.2.3 Currax Weight-loss Drugs Product and Services
2.2.4 Currax Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Currax Recent Developments/Updates
2.3 Ultimate life ltd
2.3.1 Ultimate life ltd Details
2.3.2 Ultimate life ltd Major Business
2.3.3 Ultimate life ltd Weight-loss Drugs Product and Services
2.3.4 Ultimate life ltd Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ultimate life ltd Recent Developments/Updates
2.4 Wolfson Berg Ltd
2.4.1 Wolfson Berg Ltd Details
2.4.2 Wolfson Berg Ltd Major Business
2.4.3 Wolfson Berg Ltd Weight-loss Drugs Product and Services
2.4.4 Wolfson Berg Ltd Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wolfson Berg Ltd Recent Developments/Updates
2.5 Swiss Research Labs Ltd.
2.5.1 Swiss Research Labs Ltd. Details
2.5.2 Swiss Research Labs Ltd. Major Business
2.5.3 Swiss Research Labs Ltd. Weight-loss Drugs Product and Services
2.5.4 Swiss Research Labs Ltd. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Swiss Research Labs Ltd. Recent Developments/Updates
2.6 Roar Ambition
2.6.1 Roar Ambition Details
2.6.2 Roar Ambition Major Business
2.6.3 Roar Ambition Weight-loss Drugs Product and Services
2.6.4 Roar Ambition Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Roar Ambition Recent Developments/Updates
2.7 Health and Nutrition Ltd.
2.7.1 Health and Nutrition Ltd. Details
2.7.2 Health and Nutrition Ltd. Major Business
2.7.3 Health and Nutrition Ltd. Weight-loss Drugs Product and Services
2.7.4 Health and Nutrition Ltd. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Health and Nutrition Ltd. Recent Developments/Updates
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Weight-loss Drugs Product and Services
2.8.4 Abbott Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abbott Recent Developments/Updates
2.9 Kellogg Company
2.9.1 Kellogg Company Details
2.9.2 Kellogg Company Major Business
2.9.3 Kellogg Company Weight-loss Drugs Product and Services
2.9.4 Kellogg Company Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kellogg Company Recent Developments/Updates
2.10 Glanbia PLC
2.10.1 Glanbia PLC Details
2.10.2 Glanbia PLC Major Business
2.10.3 Glanbia PLC Weight-loss Drugs Product and Services
2.10.4 Glanbia PLC Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Glanbia PLC Recent Developments/Updates
2.11 Ajinomoto Co. Inc.
2.11.1 Ajinomoto Co. Inc. Details
2.11.2 Ajinomoto Co. Inc. Major Business
2.11.3 Ajinomoto Co. Inc. Weight-loss Drugs Product and Services
2.11.4 Ajinomoto Co. Inc. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Ajinomoto Co. Inc. Recent Developments/Updates
2.12 Kraft Heinz Company
2.12.1 Kraft Heinz Company Details
2.12.2 Kraft Heinz Company Major Business
2.12.3 Kraft Heinz Company Weight-loss Drugs Product and Services
2.12.4 Kraft Heinz Company Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Kraft Heinz Company Recent Developments/Updates
2.13 GlaxoSmithKline PLC
2.13.1 GlaxoSmithKline PLC Details
2.13.2 GlaxoSmithKline PLC Major Business
2.13.3 GlaxoSmithKline PLC Weight-loss Drugs Product and Services
2.13.4 GlaxoSmithKline PLC Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 GlaxoSmithKline PLC Recent Developments/Updates
2.14 Herbalife Nutrition Ltd.
2.14.1 Herbalife Nutrition Ltd. Details
2.14.2 Herbalife Nutrition Ltd. Major Business
2.14.3 Herbalife Nutrition Ltd. Weight-loss Drugs Product and Services
2.14.4 Herbalife Nutrition Ltd. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Herbalife Nutrition Ltd. Recent Developments/Updates
2.15 PepsiCo
2.15.1 PepsiCo Details
2.15.2 PepsiCo Major Business
2.15.3 PepsiCo Weight-loss Drugs Product and Services
2.15.4 PepsiCo Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 PepsiCo Recent Developments/Updates
2.16 Nestle
2.16.1 Nestle Details
2.16.2 Nestle Major Business
2.16.3 Nestle Weight-loss Drugs Product and Services
2.16.4 Nestle Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Nestle Recent Developments/Updates
2.17 Amway Corp.
2.17.1 Amway Corp. Details
2.17.2 Amway Corp. Major Business
2.17.3 Amway Corp. Weight-loss Drugs Product and Services
2.17.4 Amway Corp. Weight-loss Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Amway Corp. Recent Developments/Updates
3 Competitive Environment: Weight-loss Drugs by Manufacturer
3.1 Global Weight-loss Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Weight-loss Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Weight-loss Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Weight-loss Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Weight-loss Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Weight-loss Drugs Manufacturer Market Share in 2022
3.5 Weight-loss Drugs Market: Overall Company Footprint Analysis
3.5.1 Weight-loss Drugs Market: Region Footprint
3.5.2 Weight-loss Drugs Market: Company Product Type Footprint
3.5.3 Weight-loss Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Weight-loss Drugs Market Size by Region
4.1.1 Global Weight-loss Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Weight-loss Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Weight-loss Drugs Average Price by Region (2018-2029)
4.2 North America Weight-loss Drugs Consumption Value (2018-2029)
4.3 Europe Weight-loss Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Weight-loss Drugs Consumption Value (2018-2029)
4.5 South America Weight-loss Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Weight-loss Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Weight-loss Drugs Sales Quantity by Type (2018-2029)
5.2 Global Weight-loss Drugs Consumption Value by Type (2018-2029)
5.3 Global Weight-loss Drugs Average Price by Type (2018-2029)
6 Market Segment by Sales Channels
6.1 Global Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
6.2 Global Weight-loss Drugs Consumption Value by Sales Channels (2018-2029)
6.3 Global Weight-loss Drugs Average Price by Sales Channels (2018-2029)
7 North America
7.1 North America Weight-loss Drugs Sales Quantity by Type (2018-2029)
7.2 North America Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
7.3 North America Weight-loss Drugs Market Size by Country
7.3.1 North America Weight-loss Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Weight-loss Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Weight-loss Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
8.3 Europe Weight-loss Drugs Market Size by Country
8.3.1 Europe Weight-loss Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Weight-loss Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Weight-loss Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
9.3 Asia-Pacific Weight-loss Drugs Market Size by Region
9.3.1 Asia-Pacific Weight-loss Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Weight-loss Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Weight-loss Drugs Sales Quantity by Type (2018-2029)
10.2 South America Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
10.3 South America Weight-loss Drugs Market Size by Country
10.3.1 South America Weight-loss Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Weight-loss Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Weight-loss Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Weight-loss Drugs Sales Quantity by Sales Channels (2018-2029)
11.3 Middle East & Africa Weight-loss Drugs Market Size by Country
11.3.1 Middle East & Africa Weight-loss Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Weight-loss Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Weight-loss Drugs Market Drivers
12.2 Weight-loss Drugs Market Restraints
12.3 Weight-loss Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Weight-loss Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Weight-loss Drugs
13.3 Weight-loss Drugs Production Process
13.4 Weight-loss Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Weight-loss Drugs Typical Distributors
14.3 Weight-loss Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Weight-loss Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Weight-loss Drugs Consumption Value by Sales Channels, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Weight-loss Drugs Product and Services
Table 6. Novo Nordisk Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Currax Basic Information, Manufacturing Base and Competitors
Table 9. Currax Major Business
Table 10. Currax Weight-loss Drugs Product and Services
Table 11. Currax Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Currax Recent Developments/Updates
Table 13. Ultimate life ltd Basic Information, Manufacturing Base and Competitors
Table 14. Ultimate life ltd Major Business
Table 15. Ultimate life ltd Weight-loss Drugs Product and Services
Table 16. Ultimate life ltd Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Ultimate life ltd Recent Developments/Updates
Table 18. Wolfson Berg Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Wolfson Berg Ltd Major Business
Table 20. Wolfson Berg Ltd Weight-loss Drugs Product and Services
Table 21. Wolfson Berg Ltd Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wolfson Berg Ltd Recent Developments/Updates
Table 23. Swiss Research Labs Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Swiss Research Labs Ltd. Major Business
Table 25. Swiss Research Labs Ltd. Weight-loss Drugs Product and Services
Table 26. Swiss Research Labs Ltd. Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Swiss Research Labs Ltd. Recent Developments/Updates
Table 28. Roar Ambition Basic Information, Manufacturing Base and Competitors
Table 29. Roar Ambition Major Business
Table 30. Roar Ambition Weight-loss Drugs Product and Services
Table 31. Roar Ambition Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Roar Ambition Recent Developments/Updates
Table 33. Health and Nutrition Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Health and Nutrition Ltd. Major Business
Table 35. Health and Nutrition Ltd. Weight-loss Drugs Product and Services
Table 36. Health and Nutrition Ltd. Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Health and Nutrition Ltd. Recent Developments/Updates
Table 38. Abbott Basic Information, Manufacturing Base and Competitors
Table 39. Abbott Major Business
Table 40. Abbott Weight-loss Drugs Product and Services
Table 41. Abbott Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Abbott Recent Developments/Updates
Table 43. Kellogg Company Basic Information, Manufacturing Base and Competitors
Table 44. Kellogg Company Major Business
Table 45. Kellogg Company Weight-loss Drugs Product and Services
Table 46. Kellogg Company Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kellogg Company Recent Developments/Updates
Table 48. Glanbia PLC Basic Information, Manufacturing Base and Competitors
Table 49. Glanbia PLC Major Business
Table 50. Glanbia PLC Weight-loss Drugs Product and Services
Table 51. Glanbia PLC Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Glanbia PLC Recent Developments/Updates
Table 53. Ajinomoto Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Ajinomoto Co. Inc. Major Business
Table 55. Ajinomoto Co. Inc. Weight-loss Drugs Product and Services
Table 56. Ajinomoto Co. Inc. Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Ajinomoto Co. Inc. Recent Developments/Updates
Table 58. Kraft Heinz Company Basic Information, Manufacturing Base and Competitors
Table 59. Kraft Heinz Company Major Business
Table 60. Kraft Heinz Company Weight-loss Drugs Product and Services
Table 61. Kraft Heinz Company Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Kraft Heinz Company Recent Developments/Updates
Table 63. GlaxoSmithKline PLC Basic Information, Manufacturing Base and Competitors
Table 64. GlaxoSmithKline PLC Major Business
Table 65. GlaxoSmithKline PLC Weight-loss Drugs Product and Services
Table 66. GlaxoSmithKline PLC Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. GlaxoSmithKline PLC Recent Developments/Updates
Table 68. Herbalife Nutrition Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Herbalife Nutrition Ltd. Major Business
Table 70. Herbalife Nutrition Ltd. Weight-loss Drugs Product and Services
Table 71. Herbalife Nutrition Ltd. Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Herbalife Nutrition Ltd. Recent Developments/Updates
Table 73. PepsiCo Basic Information, Manufacturing Base and Competitors
Table 74. PepsiCo Major Business
Table 75. PepsiCo Weight-loss Drugs Product and Services
Table 76. PepsiCo Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. PepsiCo Recent Developments/Updates
Table 78. Nestle Basic Information, Manufacturing Base and Competitors
Table 79. Nestle Major Business
Table 80. Nestle Weight-loss Drugs Product and Services
Table 81. Nestle Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Nestle Recent Developments/Updates
Table 83. Amway Corp. Basic Information, Manufacturing Base and Competitors
Table 84. Amway Corp. Major Business
Table 85. Amway Corp. Weight-loss Drugs Product and Services
Table 86. Amway Corp. Weight-loss Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Amway Corp. Recent Developments/Updates
Table 88. Global Weight-loss Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 89. Global Weight-loss Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Weight-loss Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in Weight-loss Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Weight-loss Drugs Production Site of Key Manufacturer
Table 93. Weight-loss Drugs Market: Company Product Type Footprint
Table 94. Weight-loss Drugs Market: Company Product Application Footprint
Table 95. Weight-loss Drugs New Market Entrants and Barriers to Market Entry
Table 96. Weight-loss Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Weight-loss Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 98. Global Weight-loss Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 99. Global Weight-loss Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Weight-loss Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Weight-loss Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global Weight-loss Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global Weight-loss Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Global Weight-loss Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Global Weight-loss Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Weight-loss Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Weight-loss Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global Weight-loss Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global Weight-loss Drugs Sales Quantity by Sales Channels (2018-2023) & (K Units)
Table 110. Global Weight-loss Drugs Sales Quantity by Sales Channels (2024-2029) & (K Units)
Table 111. Global Weight-loss Drugs Consumption Value by Sales Channels (2018-2023) & (USD Million)
Table 112. Global Weight-loss Drugs Consumption Value by Sales Channels (2024-2029) & (USD Million)
Table 113. Global Weight-loss Drugs Average Price by Sales Channels (2018-2023) & (US$/Unit)
Table 114. Global Weight-loss Drugs Average Price by Sales Channels (2024-2029) & (US$/Unit)
Table 115. North America Weight-loss Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 116. North America Weight-loss Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 117. North America Weight-loss Drugs Sales Quantity by Sales Channels (2018-2023) & (K Units)
Table 118. North America Weight-loss Drugs Sales Quantity by Sales Channels (2024-2029) & (K Units)
Table 119. North America Weight-loss Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 120. North America Weight-loss Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 121. North America Weight-loss Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Weight-loss Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Weight-loss Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 124. Europe Weight-loss Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 125. Europe Weight-loss Drugs Sales Quantity by Sales Channels (2018-2023) & (K Units)
Table 126. Europe Weight-loss Drugs Sales Quantity by Sales Channels (2024-2029) & (K Units)
Table 127. Europe Weight-loss Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 128. Europe Weight-loss Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 129. Europe Weight-loss Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Weight-loss Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Weight-loss Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 132. Asia-Pacific Weight-loss Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 133. Asia-Pacific Weight-loss Drugs Sales Quantity by Sales Channels (2018-2023) & (K Units)
Table 134. Asia-Pacific Weight-loss Drugs Sales Quantity by Sales Channels (2024-2029) & (K Units)
Table 135. Asia-Pacific Weight-loss Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 136. Asia-Pacific Weight-loss Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 137. Asia-Pacific Weight-loss Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Weight-loss Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Weight-loss Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 140. South America Weight-loss Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 141. South America Weight-loss Drugs Sales Quantity by Sales Channels (2018-2023) & (K Units)
Table 142. South America Weight-loss Drugs Sales Quantity by Sales Channels (2024-2029) & (K Units)
Table 143. South America Weight-loss Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 144. South America Weight-loss Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 145. South America Weight-loss Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Weight-loss Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Weight-loss Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 148. Middle East & Africa Weight-loss Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 149. Middle East & Africa Weight-loss Drugs Sales Quantity by Sales Channels (2018-2023) & (K Units)
Table 150. Middle East & Africa Weight-loss Drugs Sales Quantity by Sales Channels (2024-2029) & (K Units)
Table 151. Middle East & Africa Weight-loss Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 152. Middle East & Africa Weight-loss Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 153. Middle East & Africa Weight-loss Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Weight-loss Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Weight-loss Drugs Raw Material
Table 156. Key Manufacturers of Weight-loss Drugs Raw Materials
Table 157. Weight-loss Drugs Typical Distributors
Table 158. Weight-loss Drugs Typical Customers
List of Figures
Figure 1. Weight-loss Drugs Picture
Figure 2. Global Weight-loss Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Weight-loss Drugs Consumption Value Market Share by Type in 2022
Figure 4. Liquid Examples
Figure 5. Powder Examples
Figure 6. Softgels Examples
Figure 7. Pills Examples
Figure 8. Others Examples
Figure 9. Global Weight-loss Drugs Consumption Value by Sales Channels, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Weight-loss Drugs Consumption Value Market Share by Sales Channels in 2022
Figure 11. Online Sales Examples
Figure 12. Hospitals and Clinics Examples
Figure 13. Pharmacy Examples
Figure 14. Others Examples
Figure 15. Global Weight-loss Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Weight-loss Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Weight-loss Drugs Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Weight-loss Drugs Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Weight-loss Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Weight-loss Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Weight-loss Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Weight-loss Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Weight-loss Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Weight-loss Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Weight-loss Drugs Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Weight-loss Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Weight-loss Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Weight-loss Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Weight-loss Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Weight-loss Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Weight-loss Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Weight-loss Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Weight-loss Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Weight-loss Drugs Sales Quantity Market Share by Sales Channels (2018-2029)
Figure 35. Global Weight-loss Drugs Consumption Value Market Share by Sales Channels (2018-2029)
Figure 36. Global Weight-loss Drugs Average Price by Sales Channels (2018-2029) & (US$/Unit)
Figure 37. North America Weight-loss Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Weight-loss Drugs Sales Quantity Market Share by Sales Channels (2018-2029)
Figure 39. North America Weight-loss Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Weight-loss Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Weight-loss Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Weight-loss Drugs Sales Quantity Market Share by Sales Channels (2018-2029)
Figure 46. Europe Weight-loss Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Weight-loss Drugs Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Weight-loss Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Weight-loss Drugs Sales Quantity Market Share by Sales Channels (2018-2029)
Figure 55. Asia-Pacific Weight-loss Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Weight-loss Drugs Consumption Value Market Share by Region (2018-2029)
Figure 57. China Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Weight-loss Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Weight-loss Drugs Sales Quantity Market Share by Sales Channels (2018-2029)
Figure 65. South America Weight-loss Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Weight-loss Drugs Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Weight-loss Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Weight-loss Drugs Sales Quantity Market Share by Sales Channels (2018-2029)
Figure 71. Middle East & Africa Weight-loss Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Weight-loss Drugs Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Weight-loss Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Weight-loss Drugs Market Drivers
Figure 78. Weight-loss Drugs Market Restraints
Figure 79. Weight-loss Drugs Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Weight-loss Drugs in 2022
Figure 82. Manufacturing Process Analysis of Weight-loss Drugs
Figure 83. Weight-loss Drugs Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
